 | Monter d'un niveau |
Réseau de collaborationCe graphique trace les liens entre tous les collaborateurs des publications de {} figurant sur cette page.
Chaque lien représente une collaboration sur la même publication. L'épaisseur du lien représente le nombre de collaborations.
Utilisez la molette de la souris ou les gestes de défilement pour zoomer à l'intérieur du graphique.
Vous pouvez cliquer sur les noeuds et les liens pour les mettre en surbrillance et déplacer les noeuds en les glissant.
Enfoncez la touche "Ctrl" ou la touche "⌘" en cliquant sur les noeuds pour ouvrir la liste des publications de cette personne.
Alameh, M.-G., Lavertu, M., Merzouki, A., Biniecki, K., & Buschmann, M. D. (mai 2014). Chitosan/siRNA nanoparticles demonstrate superior silencing efficiency and lower toxicity compared to lipid nanoparticles [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC. Publié dans Molecular Therapy, 22(S1). Disponible
Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible
Alamech, M., Jean, M., DeJesus, D., Buschmann, M. D., & Merzouki, A. (2010). Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. International Journal of Nanomedicine, 5, 473-481. Disponible
Buschmann, M. D., Merzouki, A., Lavertu, M., Thibault, M., Jean, M., & Darras, V. (2013). Chitosans for delivery of nucleic acids. Advanced Drug Delivery Reviews, 65(9), 1234-1270. Lien externe
Buschmann, M. D., Thibault, M., Merzouki, A., Lavertu, M., Ma, P. L., Jean, M., Darras, V., & Winnik, F. M. (mai 2010). Polynucleotide delivery with chitosans [Communication écrite]. 93rd Canadian Chemistry Conference, Toronto, Ontario. Non disponible
Buschmann, M. D., Thibault, M., Merzouki, A., & Lavertu, M. (août 2009). Polynucleotide delivery with chitosans [Communication écrite]. 8th World Congress of Chemical Engineering, Montréal, Québec. Non disponible
DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (mai 2011). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible
Jean, M., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). Combining delivery of GLP-1 gene expressing plasmid and DPP-4 gene silencing siRNA using Chitosan-based nanoparticles for Type-2 Diabetes treatment [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
Jean, M., Derbali, R., DeJesus, D., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). Apolipoprotein B knock-down by Chitosan/ApoB-siRNA nanoparticles lowers plasma cholesterol in atherosclerosis mouse model [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
Jean, M., Behhammadi, M., Sidique, A., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). P-Glycoprotein knock-down by Chitosan/Mdr1-siRNA nanoparticles increases sensitivity to chemotherapeutics [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
Jean, M., Alameh, M., De Jesus, D., Thibault, M., Lavertu, M., Darras, V., Nelea, M., Buschmann, M. D., & Merzouki, A. (2012). Chitosan-Based Therapeutic Nanoparticles for Combination Gene Therapy and Gene Silencing of in Vitro Cell Lines Relevant to Type 2 Diabetes. European Journal of Pharmaceutical Sciences, 45(1-2), 138-149. Lien externe
Jean, M., Alamech, M., Buschmann, M. D., & Merzouki, A. (2011). Effective and safe gene-based delivery of GLP using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of diabetes. Gene Therapy, 18(8), 807-816. Lien externe
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Non disponible
Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Non disponible
Jean, M., Smaoui, F., Lavertu, M., Methot, S., Bouhdoud, L., Buschmann, M. D., & Merzouki, A. (2009). Chitosan-Plasmid Nanoparticle Formulations for Im and Sc Delivery of Recombinant Fgf-2 and Pdgf-Bb or Generation of Antibodies. Gene Therapy, 16(9), 1097-1110. Lien externe
Liberelle, B., Merzouki, A., & De Crescenzo, G. (2013). Immobilized Carboxymethylated Dextran Coatings for Enhanced ELISA. Journal of Immunological Methods, 389(1-2), 38-44. Lien externe
Liberelle, B., Bartholin, L., Boucher, C., Murschel, F., Jolicoeur, M., Durocher, Y., Merzouki, A., & De Crescenzo, G. (2010). New Elisa Approach Based on Coiled-Coil Interactions. Journal of Immunological Methods, 362(1-2), 161-167. Lien externe
Merzouki, A., & Buschmann, M. D. (2017). Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes. (Brevet no US9809821). Lien externe
Merzouki, A., & Buschmann, M. D. (2013). Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1. (Demande de brevet no US20130210717). Lien externe
Merzouki, A., Buschmann, M. D., Jean, M., Young, R. S., Liao, S., Gal, S., Li, Z., & Slilaty, S. N. (2012). Adva-27a, a Novel Podophyllotoxin Derivative Found to Be Effective Against Multidrug Resistant Human Cancer Cells. Anticancer Research, 32(10), 4423-4432. Lien externe
Merzouki, A., Alameh, M., DeJesus, D., Jean, M., Darras, V., Thibault, M., Lavertu, M., & Buschmann, M. D. (2012). Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. International Journal of Nanomedicine, 7, 1399-1414. Disponible
Méthot, S., Lavertu, M., Sun, J., Smaoui, F., Jean, M., Merzouki, A., & Buschmann, M. D. (septembre 2007). Efficient in vivo gene delivery using chitosan/DNA nanoparticles for applications in cartilage repair [Communication écrite]. 7th World Congress International Society for Cartilage Repair, Warsaw, Poland. Lien externe
Sabbahi, R., Lavallée, R., Merzouki, A., & Guertin, C. (2010). Differentiation of entomopathogenic fungus Beauveria bassiana (Ascomycetes: Hypocreales) isolates by PCR-RFLP. [Différentiation d’isolats du champignon entomopathogène Beauveria bassiana (Ascomycetes : Hypocreales) par PCR-RFLP]. Phytoprotection, 90(2), 49-56. Lien externe
Smaoui, F., Buschmann, M. D., Jean, M., Bouhdoud, L., Henrichon, M., Méthot, S., & Merzouki, A. (juin 2006). The chitosan used as a delivery system of therapeutic growth factors for the induction of cartilage regeneration [Communication écrite]. Canadian Society of Microbiologists Annual Conference, London, Ontario. Non disponible
Thibault, M., Astolfi, M., Tran-Khanh, N., Lavertu, M., Darras, V., Merzouki, A., & Buschmann, M. D. (mai 2011). Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible
Thibault, M., Astolfi, M., Tran-Khanh, N., Lavertu, M., Darras, V., Merzouki, A., & Buschmann, M. D. (2011). Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials, 32(20), 4639-4646. Lien externe
